IEMbase 0587: VPS11-related hypomyelinating leukodystrophy type 12
Scope
| Field | Value |
|---|---|
| IEMbase ID | 587 |
| Nosology | 19.4.02.01 |
| Gene | VPS11 |
| External IDs | OMIM:616683; ORPHA:466934 |
| Generated mapping | UNMAPPED; best candidate Hypomyelinating_Leukodystrophy_7.yaml |
| Candidate DisMech targets | None exact |
| Review date | 2026-07-07 |
IEMbase phenotype signal
IEMbase represents VPS11-related hypomyelinating leukodystrophy type 12 / HLD12. The record is autosomal recessive, classified under disorders of lysosome-related organelle biogenesis, has unknown treatability, and has no treatment rows.
Biochemical rows include increased urinary monohexosylceramides, sulfatide, and tetrahexosylceramides. Clinical rows include blindness, hearing loss, hypotonia, spasticity, cerebral hypomyelination, cerebellar white-matter MRI abnormalities, thin corpus callosum, and temperature instability.
DisMech phenotype coverage
Hypomyelinating_Leukodystrophy_7.yaml is a phenotype-class false-positive
candidate. It models POLR3A/POLR3B-related leukodystrophy / 4H syndrome through
RNA polymerase III transcriptional dysfunction, not VPS11, HOPS/endolysosomal
trafficking, lysosome-related organelle biogenesis, or urinary
glycosphingolipid/sulfatide abnormalities.
The local knowledge base contains other hypomyelinating leukodystrophy entries, but no exact VPS11/HLD12 target was identified.
Concordance and completeness
Judgement: true local gap; reject HLD7 as an exact target.
IEMbase supplies a distinct VPS11 mechanism and biomarker profile that should remain separate from POLR3-related leukodystrophy. The overlapping hypomyelination, spasticity, and motor features explain the generated match but are not sufficient for disease identity.
Curation actions
- Create or identify an exact VPS11/HLD12 target before import.
- Reject
Hypomyelinating_Leukodystrophy_7.yamlas an exact mapping. - Preserve the urinary glycosphingolipid/sulfatide, cerebral hypomyelination, cerebellar white-matter, thin corpus callosum, blindness, hearing-loss, hypotonia/spasticity, and temperature-instability prompts.